scispace - formally typeset
F

Florian Kuchenbauer

Researcher at University of British Columbia

Publications -  105
Citations -  6591

Florian Kuchenbauer is an academic researcher from University of British Columbia. The author has contributed to research in topics: Myeloid leukemia & Leukemia. The author has an hindex of 31, co-authored 95 publications receiving 5814 citations. Previous affiliations of Florian Kuchenbauer include BC Cancer Agency & Vancouver General Hospital.

Papers
More filters
Journal ArticleDOI

Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells.

TL;DR: Application of this approach to RNA from human embryonic stem cells obtained before and after their differentiation into embryoid bodies revealed the sequences and expression levels of 334 known plus 104 novel miRNA genes, representing the deepest miRNA sampling to date.
Journal ArticleDOI

Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotype

TL;DR: Deletes chromosome 5q and identifies Toll–interleukin-1 receptor domain–containing adaptor protein (TIRAP) and tumor necrosis factor receptor–associated factor-6 (TRAF6) as respective targets of these miRNAs.
Journal ArticleDOI

The Lin28b–let-7–Hmga2 axis determines the higher self-renewal potential of fetal haematopoietic stem cells

TL;DR: Mouse haematopoietic stem cells undergo a postnatal transition in several properties, including a marked reduction in their self-renewal activity, and it is shown that the developmentally timed change in this key function of HSCs is associated with their decreased expression of Lin28b and an accompanying increase in their let-7 microRNA levels.
Journal ArticleDOI

Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells.

Nimitha R. Mathew, +141 more
- 10 Apr 2018 - 
TL;DR: Findings indicate that the synergism of T cells and sorafenib is mediated via reduced ATF4 expression, causing activation of the IRF7–IL-15 axis in leukemia cells and thereby leading to metabolic reprogramming of leukemia-reactive T cells in humans.